Joanna Poutou

Enhanced therapeutic effect using sequential administration of antigenically distinct oncolytic viruses expressing oncostatin M in a Syrian hamster orthotopic pancreatic cancer model.

Implications for SARS-CoV-2 Vaccine Design: Fusion of Spike Glycoprotein Transmembrane Domain to Receptor-Binding Domain Induces Trimerization.

Redirecting oncolytic viruses: Engineering opportunists to take control of the tumour microenvironment.

Nanoluciferase complementation-based bioreporter reveals the importance of N-linked glycosylation of SARS-CoV-2 S for viral entry.

Characterization of Critical Determinants of ACE2-SARS CoV-2 RBD Interaction.

A High-Throughput NanoBiT-Based Serological Assay Detects SARS-CoV-2 Seroconversion.